APHD VERDE BIO HOLDINGS, INC.

APHD financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1490054 Exchange: OTC SIC: 1311 (Crude Petroleum & Natural Gas) Latest filing: 10-Q filed Mar 25, 2024 Data checked: Oct 21, 2026
Showing 3 of 14 annual and 0 of 51 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$2.52M (Oct 2022)
Industry (SIC)
1311 Crude Petroleum & Natural Gas
Incorporated
NV
Fiscal Year End
April (0430)
Phone
(205) 864-5377
EIN
300678378
Headquarters
FRISCO, TX, 75034
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: APPIPHANY TECHNOLOGIES HOLDINGS CORP (2010–2020)

▼ Key Metrics (TTM)

As of Jan 31, 2024
Financials
Revenue
-
Net Income
$-2.66M
Total Assets
$1.88M
Total Equity
$119.02K
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
-2237.5%
Return on Assets
-141.5%

▼ FY 2023 Summary Analysis

Annual report ending Apr 30, 2023

Overview and Growth

In fiscal 2023, VERDE BIO HOLDINGS, INC. reported net loss of $1.86M. Total assets stood at $4.16M, showing the scale of resources supporting revenue, earnings, liquidity, and financing.

Profitability

The company recorded an operating loss of $1.64M after the reported operating expense base. After all below-operating-line items, the company recorded a net loss of $1.86M for the fiscal year. Negative EBITDA totaled $1.55M, confirming that the earnings deficit remained before depreciation and amortization. The company reported a pretax loss of $1.77M, before the effect of income taxes. The company recognized $0.00 of income tax for the period, completing the transition from pretax income to net income. The loss-to-equity relationship was 80.3%, placing the bottom-line deficit against shareholder capital. The loss-to-assets relationship was 44.8%, placing the bottom-line deficit against the company’s resource base. The bottom-line deficit decreased from $3.44M in fiscal 2022 to $1.86M.

Liquidity and Capital Structure

Total assets were $4.16M, supported by $1.84M of liabilities and $2.32M of shareholder equity. The near-term balance sheet paired $97.75K of current assets with $1.84M of current liabilities at the reporting date. Current assets covered only 0.05x of current liabilities, so current liabilities exceeded current assets at period end. Cash and equivalents totaled $25.84K, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 1.4% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Equity equaled 55.8% of assets, showing the shareholder-capital layer within the company’s balance sheet. Relative to total assets, liabilities measured 44.2%, complementing the separate equity-based view of the company’s capital structure. Cash and equivalents equaled 0.6% of total assets, showing the liquid cash component within the company’s broader resource base. Compared with $5.09M in fiscal 2022, the current asset base moved 18.2% and finished lower. Book equity was 35.7% lower than fiscal 2022 equity of $3.61M, showing how shareholder capital changed year over year. Cash and equivalents were 81.7% lower than fiscal 2022 cash of $141.21K, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $872.23K, showing that operations absorbed cash during the period. Capital spending of $6.99K added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. Operating cash flow and capital spending combined to leave a $879.21K cash deficit after capital spending. The free-cash-flow deficit equaled 21.1% of total assets, placing the cash shortfall against the company’s resource base. Cash absorbed by operations decreased from $1.15M in fiscal 2022 to $872.23K.
Based on the annual report for the fiscal year ending Apr 30, 2023. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for VERDE BIO HOLDINGS, INC.
Metric FY2023 📄 FY2022 📄 FY2021 📄
Income Statement
REVENUE
Gross Profit - - $-1.67K
OPERATING EXPENSES
Operating Income $-1.64M $-3.15M $-2.97M
NON-OPERATING INCOME / EXPENSE
Interest Expense $65.88K $0 $366.06K
Other Income/Expense $-134.25K $-272.03K $-348.93K
Pretax Income $-1.77M $-3.42M $-3.32M
Income Tax $0 $0 $0
Net Income $-1.86M $-3.44M $0
PER SHARE & SUPPLEMENTAL
EBITDA $-1.55M $-3.12M $-2.97M
Depreciation & Amortization $87.46K $25.87K $0
Balance Sheet
ASSETS
Cash & Equivalents $25.84K $141.21K $2.09M
Other Current Assets $0 $28.84K $32.39K
Current Assets $97.75K $295.87K $2.21M
PP&E (Net) $2.72M $2.78M $0
Noncurrent Assets $4.06M $4.79M $1.01M
Total Assets $4.16M $5.09M $3.22M
LIABILITIES
Accounts Payable $286.97K $168.24K $211.77K
Current Liabilities $1.84M $1.45M $484.01K
Noncurrent Liabilities $0 $21.34K $78.23K
Total Liabilities $1.84M $1.47M $562.24K
EQUITY
Common Stock $1.54M $1.18M $683.09K
Additional Paid-in Capital $16.70M $16.67M $12.13M
Retained Earnings $-16.03M $-14.26M $-10.84M
Total Equity $2.32M $3.61M $2.66M
Total Liabilities & Equity $4.16M $5.09M $3.22M
SUPPLEMENTAL
Shares Outstanding 1.54B 1.18B 683.08M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-872.23K $-1.15M $-685.16K
Capital Expenditures $6.99K $2.87M -
Cash from Investing $148.02K $-5.68M $-2.50M
Cash from Financing $608.84K $4.88M $5.27M
Free Cash Flow $-879.21K $-4.02M -
Beginning Cash (CFS) $141.21K $2.09M $1.63K
Net Change in Cash $-115.37K $-1.95M $2.09M
Effect of FX on Cash - - -
Calculated Ending Cash $25.84K $141.21K $2.09M
Cash per BS $25.84K $141.21K $2.09M
Cash scope difference (CFS − BS) - - -
Cash per CFS $25.84K $141.21K $2.09M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

Is VERDE BIO HOLDINGS, INC. profitable?

No. VERDE BIO HOLDINGS, INC. reported $-2.66M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.